Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02118948 · ClinicalTrials.gov registry record · NA
Development of a Novel HIV Risk Reduction Intervention for Abused Women
A NA study of Sexual Behavior, sponsored by The Miriam Hospital.
- Completed
- Registry status
- NA
- Development phase
- 86
- Enrollment target
- 1
- Study location
NCT02118948: Completed NA study of Sexual Behavior, sponsored by The Miriam Hospital.
NCT02118948 is a NA study of Sexual Behavior that has completed, run by The Miriam Hospital. The registered enrollment target is 86 participants, below the 3,423-participant average among 20 other Sexual Behavior trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02118948, a NA study of Sexual Behavior, has completed, sponsored by The Miriam Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 86 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop and evaluate an HIV risk reduction intervention for women with a history of abuse.
Primary Outcome
at baseline and at 3 months post intervention, participants will respond to the question, "How many sexual partners have you had in the past 3 months?", assessed by computerized survey
Conditions Studied
Interventions
- BEHAVIORAL Abuse-focused intervention
- BEHAVIORAL Sexual behavior-focused intervention
Study Locations (1)
New York
- University of Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2014-04 |
| Est. Completion | 2016-07 |
| Phase | NA |
What the finished NCT02118948 record still lists
NCT02118948 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 86 participants, a relatively small participant target, below the 3,423-participant average among 20 other Sexual Behavior trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Sexual Behavior appearing as the primary indexed condition, and to 2 interventions - of which Abuse-focused intervention is the first listed.
NCT02118948 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02118948 about?
NCT02118948 is a clinical study titled "Development of a Novel HIV Risk Reduction Intervention for Abused Women". The purpose of this study is to develop and evaluate an HIV risk reduction intervention for women with a history of abuse.
What is the current status of trial NCT02118948?
This trial is currently completed. It is a NA study. The enrollment target is 86 participants. The study started on 2014-04. Estimated completion is 2016-07.
What conditions does trial NCT02118948 study?
This clinical trial studies the following conditions: Sexual Behavior.
What interventions are being tested in trial NCT02118948?
The interventions under investigation include: Abuse-focused intervention (BEHAVIORAL), Sexual behavior-focused intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02118948?
This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02118948 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sexual Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02118948's enrollment target sits among peer trials
86 18th of 20 higher than 3 of 20 other Sexual Behavior trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sexual Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Parent Toolkit 2.0 (Morehouse Family Health Study)
RECRUITING · NA
-
Optimizing a Digital AEP Risk Intervention With Native Women and Communities
RECRUITING · NA
-
Rigorous Evaluation of Let's Talk Birth Control
RECRUITING · NA
-
Young Adult Education on Alcohol & Health
RECRUITING · NA
-
Journey of Transformation Curriculum for Native American Youth
RECRUITING · NA
-
IMARA for Black Male Caregivers and Girls Empowerment (IMAGE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01639508 · 86 participants · Phase 2
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
- NCT03519269 · 86 participants · NA
Navio Robotic Versus Conventional Total Knee Arthroplasty
- NCT04132999 · 86 participants · NA
PAP for Children With DS and OSAS
- NCT04545957 · 86 participants · NA
Jump: MR Simulation For Radiation Therapy Master Protocol
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia